Stocks UBS Financial statements
Financial statementsUBS Group AG financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data UBS Group AG files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28,766 | 29,754 | 30,330 | 28,967 | 33,084 | 35,393 | ||||
| General and administrative | 716 | 612 | 590 | 551 | 565 | |||||
| Pre-tax income | 4,209 | 5,351 | 5,991 | 5,577 | 8,155 | 9,484 | 9,604 | 28,255 | 6,821 | 8,853 |
| Income tax | 777 | 4,305 | 1,468 | 1,267 | 1,583 | 1,998 | 1,942 | 873 | 1,675 | 1,056 |
| Net income to minority interests | 84 | 77 | 7 | 6 | 15 | 29 | 32 | 16 | 60 | 30 |
| Net income | 3,432 | 1,046 | 4,522 | 4,310 | 6,572 | 7,486 | 7,661 | 27,382 | 5,146 | 7,797 |
| EPS, basic | 0.90 | 0.26 | 1.21 | 1.17 | 1.83 | 2.14 | 2.34 | 8.68 | 1.59 | 2.46 |
| EPS, diluted | 0.88 | 0.25 | 1.18 | 1.14 | 1.77 | 2.06 | 2.25 | 8.30 | 1.52 | 2.36 |
Balance sheet
| FY2016 | FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 119,014 | 104,834 | 126,079 | 119,873 | 173,531 | 207,875 | 195,321 | 340,207 | 244,090 | 231,375 |
| Goodwill | 6,100 | 6,000 | 6,000 | 6,000 | 6,100 | |||||
| Total assets | 918,906 | 939,279 | 958,500 | 972,194 | 1,125,765 | 1,117,182 | 1,104,364 | 1,716,924 | 1,565,028 | 1,617,427 |
| Total liabilities | 886,725 | 905,429 | 917,519 | 1,066,000 | 1,056,180 | 1,047,146 | 1,630,769 | 1,479,454 | 1,526,944 | |
| Paid-in capital | 23,598 | 20,843 | 18,064 | 16,753 | 15,928 | 13,546 | 13,216 | 12,012 | 9,217 | |
| Retained earnings | 25,932 | 30,416 | 34,122 | 38,776 | 43,851 | 50,004 | 74,397 | 78,035 | 82,740 | |
| Shareholders' equity | 52,495 | 52,896 | 54,501 | 59,445 | 60,662 | 56,876 | 85,624 | 85,079 | 90,213 | |
| Minority interests | 59 | 176 | 174 | 319 | 340 | 342 | 531 | 494 | 271 | |
| Total equity | 52,554 | 53,060 | 54,675 | 59,765 | 61,002 | 57,218 | 86,156 | 85,574 | 90,484 | |
| Total liabilities and equity | 939,279 | 958,500 | 972,194 | 1,125,765 | 1,117,182 | 1,104,364 | 1,716,924 | 1,565,028 | 1,617,427 |
Cash flow statement
| FY2016 | FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 3,432 | 1,046 | 4,522 | 4,310 | 6,572 | 7,486 | 7,661 | 27,382 | 5,146 | 7,797 |
| Cash from operations | -18,292 | -52,099 | 28,913 | 19,705 | 36,958 | 31,425 | 14,647 | 86,068 | 3,279 | 21,851 |
| Cash from investing | 36,637 | 5,186 | -6,132 | -1,558 | -6,785 | -2,119 | -12,447 | 103,124 | 709 | -22,802 |
| Cash from financing | -612 | 26,988 | 190 | -25,614 | 12,432 | 10,345 | -9,094 | -58,262 | -84,165 | -30,863 |
| Exchange rate effect | -1,598 | 5,745 | -1,726 | 1,261 | 11,052 | -5,307 | -5,659 | 13,955 | -15,940 | 19,098 |
| Interest paid | 3,565 | 6,689 | 9,206 | 10,769 | 6,320 | 4,707 | 8,198 | 35,969 | 48,252 | 37,749 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Effective tax rate | 11.9% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 8.9% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 0.5% | Net income / average total assets. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Net income growth, 1y | 51.5% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 0.6% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 3.5% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 55.3% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 1.6% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 5.9% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 566.4% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 14.3% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -10.0% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 6.0% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 16.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 8.7% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 3.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 13.6% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 7.5% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Liabilities / assets | 94.4% | Total liabilities / total assets. |
| Goodwill and intangibles / assets | 0.4% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $84.11B | Shareholders' equity - goodwill - intangible assets. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $2.36 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $2.46 | Net income per basic share, as reported (split-adjusted). |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $154.15B | Share price x shares outstanding. |
| Enterprise value | -$77.23B | Market cap + total debt - cash - short-term investments. |
| P/E | 19.8x | Market cap / net income. Only when net income is positive. |
| P/B | 1.71x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1.83x | Market cap / tangible book value, when positive. |
| P/OCF | 7.05x | Market cap / cash from operations, when positive. |
| Earnings yield | 5.1% | Net income / market cap (the inverse of P/E). |
| PEG | 12.3x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
Was UBS Group AG profitable in fiscal 2025?
Yes. Net income was $7.80B, a net margin of -.